Navigation Links
Frost & Sullivan Hosts Presentation on MicroRNAs: From Stem Cells and Cancer to Diagnostics and Therapeutics
Date:3/30/2009

A Complimentary Webinar

MOUNTAIN VIEW, Calif., March 30 /PRNewswire/ --

     -  TOPIC:      The state of the microRNA market and the molecule's
                    current and potential impact on drug discovery, molecular
                    diagnostics, and personalized therapeutics.
     -  WHEN:       Tuesday, March 31, 2009
     -  TIME:       3 pm EDT
     -  LOCATION:   Online with free registration
     -  HOST:       Christi Bird, Senior Research Analyst, Healthcare
                    practice, Frost & Sullivan
     -  GUESTS:
          -  Dr. George Calin, Associate Professor, The University of Texas
             M. D. Anderson Cancer Center
          -  Alex Amiet, Senior Product Manager, Thermo Fisher Scientific


     -  This panel discussion will benefit life science research tools
        manufacturers, services providers, diagnostic companies,
        biotechnology companies, pharmaceutical companies, academic
        researchers and venture capitalists.  The outlook for the microRNA
        market will be presented from a three-pronged perspective of an
        industry analyst with knowledge of the market, a microRNA expert
        from academia, and a provider of microRNA tools and services.

Supporting Quote

"The rapid discoveries linking microRNAs to various diseases have propelled the microRNA field and tools market in recent years. Moving forward, however, the microRNA field requires more innovative studies of larger scope to make good on its lofty promise," says Bird of Frost & Sullivan.

Supporting Resources

To participate, please email Stephanie Ochoa, stephanie.ochoa@frost.com, with the following information: your full name, title, company name, company telephone number, company email address, city, state and country. Upon receipt of the above information, a registration link will be emailed to you. You may also register to receive a recorded version of the briefing at anytime by submitting the aforementioned contact details.

Frost & Sullivan's Drug Discovery practice: www.frost.com/drugdiscovery

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

    Contact:
    Stephanie Ochoa
    Frost & Sullivan
    +1.210.247.2421
    stephanie.ochoa@frost.com

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Frost & Sullivan Award Highlights Opportunity for Main Street Biotech
2. Frost & Sullivan Recognizes Life Technologies for Excellence in the Life Science Research Tools Industry
3. Frost & Sullivan Recognizes Excellence in Medical Technologies & Life Sciences
4. Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000
5. Frost & Sullivan: In Vitro Diagnostics Market
6. Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies
7. Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG
8. Frost & Sullivan Recognizes ApaTechs Leadership in Orthopedic Biologics
9. The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan
10. Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning
11. Frost & Sullivan to Present the 2009 Excellence in Medical Technologies & Life Sciences Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... Jan. 23, 2017  Alkahest Inc. ("Alkahest"), a ... neurodegenerative diseases and other age-related conditions, announced today ... as Chief Medical Officer. In this role, Dr. ... activities at Alkahest and serve on the Executive ... served as Executive Director at Dynavax, where he ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... endeavors to bring to market a pioneering medical device for the treatment of ... an engagement contract with Emergo, a global regulatory consultancy that helps companies like ...
(Date:1/20/2017)... ... January 20, 2017 , ... The two newest companies ... options for patients. Vironika, a spin out from The Wistar Institute, and Sanguis, launched ... space at 3624 Market Street. , Vironika is developing a treatment for a ...
(Date:1/19/2017)... Research and Markets has announced the addition of the ... Global Opportunity Analysis and Industry Forecast, 2014-2022" report to their ... Cancer ... reach $15,737 million by 2022 from $6,521 in 2015, growing at ... Omic technologies segment accounted for more than half of the revenue ...
Breaking Biology Technology:
(Date:12/15/2016)... HILLS, Mich. , Dec. 15, 2016  There ... unlocking car doors or starting the engine. Continental will ... in Las Vegas . Through the ... (Passive Start and Entry) and biometric elements, the international ... field of vehicle personalization and authentication. "The ...
(Date:12/8/2016)... 8, 2016 Market Research Future published a half cooked ... Mobile Biometric Security and Service Market is expected to grow over ... Market Highlights: ... Mobile Biometric Security and Service ... increasing need of authentication and security from unwanted cyber threats. The ...
(Date:12/7/2016)... AVIV, Israel , December 7, 2016 ... with the expansion of its patent portfolio, which grew to over 40 ... , , ... by its recently filed patent entitled " System, Device, and ... covers technology that enables device makers to forego costly hardware components needed ...
Breaking Biology News(10 mins):